Literature DB >> 26233927

Decreased IgM, IgA, and IgG response to pneumococcal vaccine in children with transient hypogammaglobulinemia of infancy.

Viviana Moschese1, Filomena Monica Cavaliere2, Simona Graziani3, Caterina Bilotta2, Cinzia Milito2, Loredana Chini3, Isabella Quinti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26233927     DOI： 10.1016/j.jaci.2015.06.014

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

1.  The clinical relevance of IgM and IgA anti-pneumococcal polysaccharide ELISA assays in patients with suspected antibody deficiency.

Authors:  Lisanne M A Janssen; Michiel Heron; Jean-Luc Murk; Alexander C A P Leenders; Ger T Rijkers; Esther de Vries
Journal:  Clin Exp Immunol       Date:  2021-06-01       Impact factor: 4.330

2.  Measurement of Typhim Vi IgG as a Diagnostic Tool to Determine Anti-polysaccharide Antibody Production Deficiency in Children.

Authors:  Kissy Guevara-Hoyer; Celia Gil; Antony R Parker; Leigh J Williams; Carmen Orte; Antonia Rodriguez de la Peña; Juliana Ochoa-Grullón; Edgard Rodriguez De Frias; Irene Serrano García; Sonia García-Gómez; M José Recio; Miguel Fernández-Arquero; Rebeca Pérez de Diego; Jose Tomas Ramos; Silvia Sánchez-Ramón
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

3.  Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes.

Authors:  Federica Pulvirenti; Roberta Zuntini; Cinzia Milito; Fernando Specchia; Giuseppe Spadaro; Maria Giovanna Danieli; Andrea Pession; Isabella Quinti; Simona Ferrari
Journal:  J Immunol Res       Date:  2016-03-30       Impact factor: 4.818

4.  IGA Antibody Induced by Immunization With Pneumococcal Polysaccharides Is a Prognostic Tool in Common Variable Immune Deficiencies.

Authors:  Federica Pulvirenti; Cinzia Milito; Filomena Monica Cavaliere; Ivano Mezzaroma; Francesco Cinetto; Isabella Quinti
Journal:  Front Immunol       Date:  2020-06-24       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.